NASDAQ:TBPH

Theravance Biopharma Stock Predictions

etoro logo Buy TBPH
*Your capital is at risk
$15.92
+0.340 (+2.18%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

TBPH Prediction Chart

TBPH Predictions History

Latest community submissions for TBPH.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Dec 19, 2022 $11.14 +1.55% $10.55 X 94.41% 0
Dec 19, 2022 $10.90 -0.66% $10.55 V 96.71% 1
Dec 19, 2022 $10.96 -0.12% $10.55 V 96.15% 1
JS JS Pro
Sep 28, 2021 $7.54 +1.89% $7.40 X 98.11% 1
Sep 28, 2021 $8.50 +14.86% $7.40 X 85.14% 1
JS JS Pro
Feb 10, 2020 $30.41 -0.56% $30.58 X 99.44% 4
Alan Alan Pro @Alan.115878
Feb 10, 2020 $31.08 +1.64% $30.58 X 98.36% 0
JS JS Pro
Feb 5, 2020 $29.46 -5.61% $31.21 X 94.39% 0
Michael Tyler Michael Tyler Merchant @MichaelTyler.131297
Feb 5, 2020 $30.76 -1.44% $31.21 X 98.56% 2
May 6, 2019 $25.32 +0.92% $25.09 X 99.08% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for TBPH with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT THERAVANCE BIOPHARMA
Theravance Biopharma
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective pan-janus kinase (JAK) inhibitor that is in Phase IIb/III clinical tr...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE